Skip to main content
Toggle navigation
Login
Search
Home
Tweets by PAINWeek 2022
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
Back
Favorite
0
Like
Facebook
Tweet
Print
James Hackworth, PhD
President, Brand Division
Tris Pharma, Inc.
Monmouth Junction, New Jersey
Presentation(s):
Poster Number-23 - Cebranopadol, a Novel Potent Analgesic: Binding Affinity to Opioid Receptors and In Vitro Activity
Poster Abstracts
Poster Number-22 - Cebranopadol, a Novel Potent Analgesic: Limitations in Physical Dependence Using Short- and Long-term Rodent Studies
Poster Abstracts
Poster Number-21 - Cebranopadol, a Novel Potent Analgesic: Pooled Analysis of Clinical Opiate Withdrawal Scales
Poster Abstracts
Poster Number-20 - Cebranopadol, a Novel Potent Analgesic: Review of Clinical Studies Conducted Across Multiple Types of Pain including Chronic Lower Back Bain, Acute Pain, Diabetic Peripheral Neuropathy, and Cancer Pain
Poster Abstracts